Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility. A North Carolina outsourcing facility is pulling 22 vials of ...
The U.S. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MIUDELLA for ...
Nitrosamines are substances with an N=O (N-nitroso) functional group, and toxicologists consider them to be highly toxic ...
For veterinarians who want to organize the characteristics of surgical wound classification, suture materials, and ...
Your cavity is deep, so let's remove the nerve. You need root canal treatment. When told this at a dental clinic, many people ...
A Chinese research team has validated a seven-item questionnaire that rapidly measures nurses' self-reported knowledge of ...
Morning Overview on MSN
The FDA approved Zanvastro for Alexander disease, which strikes fewer than one in a million
Zanvastro, an antisense drug from Ionis Pharmaceuticals, is now the first treatment approved by the Food and Drug ...
Transplant medicine is quietly undergoing one of its most profound conceptual shifts in decades. Writing in Frontiers in ...
Optimized Process Demonstrated Effective Removal of Procoagulant Impurities While Maintaining Immunoglobulin Quality and Increasing IgG YieldNo ...
When a healthy individual transitions from standing to sitting, coordinated motion through the lumbar spine and pelvis ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results